Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model

Journal of Functional Foods

Volumn 14, Issue , 2015, Pages 424-434

  Qiao, Yi ^a,b   Sun, Jin ^a   Xia, Shufang ^a   Li, Liting ^a   Li, Ya ^a   Wang, Panpan ^a   Shi, Yonghui ^a,b   Le, Guowei ^a,b  

^a JINING MEDICAL UNIVERSITY   (China)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

Fat storage; Inflammatory; Lactobacillus reuteri; Obesity

Indexed keywords

BACTERIA (MICROORGANISMS); LACTOBACILLUS REUTERI; MUS;

EID: 84926379019     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.02.013     Document Type: Article

References (42)

1. Ali A.A., Velasquez M.T., Hansen C.T., Mohamed A.I., Bhathena S.J. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. Journal of nutritional biochemistry 2004, 15:583-590.
2. Alkhouri N., Gornicka A., Berk M.P., Thapaliya S., Dixon L.J., Kashyap S., Schauer P.R., Feldstein A.E. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. Journal of Biological Chemistry 2010, 285:3428-3438.
3. Araujo R.L., Andrade B.M., Padron A.S., Gaidhu M.P., Perry R.L., Carvalho D.P., Ceddia R.B. High-fat diet increases thyrotropin and oxygen consumption without altering circulating 3,5,3'-triiodothyronine (T3) and thyroxine in rats: The role of iodothyronine deiodinases, reverse T3 production, and whole-body fat oxidation. Endocrinology 2010, 151:3460-3469.
4. Calcinaro F., Dionisi S., Marinaro M., Candeloro P., Bonato V., Marzotti S., Corneli R.B., Ferretti E., Gulino A., Grasso F., De Simone C., Di Mario U., Falorni A., Boirivant M., Dotta F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005, 48:1565-1575.
5. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
6. Cani P.D., Delzenne N.M. The gut microbiome as therapeutic target. Pharmacology & therapeutics 2011, 130:202-212.
7. Cerutti A., Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity 2008, 28:740-750.
8. Chen P., Zhang Q., Dang H., Liu X., Tian F., Zhao J., Chen Y., Zhang H., Chen W. Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice. Journal of Functional Foods 2014, 10:318-326.
9. de Souza C.B., Roeselers G., Troost F., Jonkers D., Koenen M., Venema K. Prebiotic effects of cassava bagasse in TNO's in vitro model of the colon in lean versus obese microbiota. Journal of Functional Foods 2014, 11:210-220.
10. Fåk F., Bäckhed F. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe-/- mice. PLoS ONE 2012, 7:e46837.
11. Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME Journal 2012, 7:880-884.
12. Gauffin C.P., Santacruz A., Moya A., Sanz Y. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS ONE 2012, 7:e41079.
13. Gutierrez-Juarez R., Pocai A., Mulas C., Ono H., Bhanot S., Monia B.P., Rossetti L. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. Journal of Clinical Investigation 2006, 116:1686-1695.
14. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., Okano M., Kagoshima M., Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 2010, 64:636-643.
15. Kim K.A., Jeong J.J., Kim D.H. Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production. Journal of Functional Foods 2015, 13:183-191.
16. Kim S.W., Park K.Y., Kim B., Kim E., Hyun C.K. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochemical and Biophysical Research Communications 2013, 431:258-263.
17. Ko K.S., Lee M., Koh J.J., Kim S.W. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Molecular Therapy 2001, 4:313-316.
18. Kruse N., Pette M., Toyka K., Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. Journal of Immunological Methods 1997, 210:195-203.
19. Laitinen K., Poussa T., Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: A randomised controlled trial. British journal of nutrition 2009, 101:1679-1687.
20. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology 2009, 53:1925-1932.
21. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
22. Li T., Owsley E., Matozel M., Hsu P., Novak C.M., Chiang J.Y. Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice. Hepatology (Baltimore, Md.) 2010, 52:678-690.
23. Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., Park O., Luo Z., Lefai E., Shyy J.Y., Gao B., Wierzbicki M., Verbeuren T.J., Shaw R.J., Cohen R.A., Zang M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metabolism 2011, 13:376-388.
24. Matarese L.E. Indirect calorimetry: Technical aspects. Journal of the American Dietetic Association 1997, 97:S154-S160.
25. Norris A.W., Hirshman M.F., Yao J., Jessen N., Musi N., Chen L., Sivitz W.I., Goodyear L.J., Kahn C.R. Endogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle. Endocrinology 2008, 149:5374-5383.
26. Pizer E.S., Wood F.D., Pasternack G.R., Kuhajda F.P. Fatty acid synthase (FAS): A target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Research 1996, 56:745-751.
27. Poutahidis T., Kleinewietfeld M., Smillie C., Levkovich T., Perrotta A., Bhela S., Varian B.J., Ibrahim Y.M., Lakritz J.R., Kearney S.M., Chatzigiagkos A., Hafler D.A., Alm E.J., Erdman S.E. Microbial reprogramming inhibits Western diet-associated obesity. PLoS ONE 2013, 8:e68596.
28. Preiss-Landl K., Zimmermann R., Hammerle G., Zechner R. Lipoprotein lipase: The regulation of tissue specific expression and its role in lipid and energy metabolism. Current Opinion in Lipidology 2002, 13:471-481.
29. Qiao Y., Sun J., Xia S., Tang X., Shi Y., Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Function 2014, 5:1241-1249.
30. Rokholm B., Baker J., Sørensen T. The levelling off of the obesity epidemic since the year 1999 - a review of evidence and perspectives. Obesity Reviews 2010, 11:835-846.
31. Saulnier D.M., Santos F., Roos S., Mistretta T.A., Spinler J.K., Molenaar D., Teusink B., Versalovic J. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS ONE 2011, 6:e18783.
32. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
33. Shen Y., Tong L. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry 2008, 47:5767-5773.
34. Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014, 63:727-735.
35. Siersbaek R., Nielsen R., Mandrup S. PPARgamma in adipocyte differentiation and metabolism - novel insights from genome-wide studies. FEBS Letters 2010, 584:3242-3249.
36. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., Marteau P., Dore J. Specificities of the fecal microbiota in inflammatory bowel disease. Inflammatory Bowel Diseases 2006, 12:106-111.
37. Terra X., Montagut G., Bustos M., Llopiz N., Ardevol A., Blade C., Fernandez-Larrea J., Pujadas G., Salvado J., Arola L., Blay M. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. Journal of Nutritional Biochemistry 2009, 20:210-218.
38. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., Dallinga-Thie G.M., Ackermans M.T., Serlie M.J., Oozeer R. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
39. Wang J., Tang H., Zhang C., Zhao Y., Derrien M., Rocher E., van-Hylckama Vlieg J.E., Strissel K., Zhao L., Obin M., Shen J. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME Journal 2014, 9:1-15.
40. Zhang C., Zhang M., Pang X., Zhao Y., Wang L., Zhao L. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME Journal 2012, 6:1848-1857.
41. Zhang C., Zhang M., Wang S., Han R., Cao Y., Hua W., Mao Y., Zhang X., Pang X., Wei C., Zhao G., Chen Y., Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME Journal 2010, 4:232-241.
42. Zhang X., Zhao Y., Zhang M., Pang X., Xu J., Kang C., Li M., Zhang C., Zhang Z., Zhang Y. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS ONE 2012, 7:e42529.